Evidence map›Paper›PMID 9430652›Full record

ArticleThe EMBO journal1998

Modulation of the intracellular stability and toxicity of diphtheria toxin through degradation by the N-end rule pathway.

P O Falnes, S Olsnes

Abstract read
In one paragraph

Article in The EMBO journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The N-end rule pathway and regulation by proteolysis.Protein science : a publication of the Protein Society · 2011
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Designing immunotoxins for cancer therapy.Immunologic research · 2002
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

P O FalnesInstitute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo. pfalnes@ulrik.uio.no
S Olsnes
Norwegian Cancer Society · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The enzymatically active A-fragment of diphtheria toxin enters the cytosol of sensitive cells where it inhibits protein synthesis by inactivating elongation factor 2 (EF-2). We have constructed a number of diphtheria toxin mutants that are degraded by the N-end rule pathway in Vero cells, and that display a wide range of intracellular stabilities. The degradation could be inhibited by the proteasome inhibitor lactacystin, indicating that the proteasome is responsible for N-end rule-mediated degradation in mammalian cells. Previously, the N-end rule has been investigated by studying the co-translational degradation of intracellularly expressed beta-galactosidase. Our work shows that a mature protein entering the cytosol from the exterior can also be degraded by the N-end rule pathway with a similar, but not identical specificity to that previously found. We found a correlation between the intracellular stability of the mutants and their toxic effect on cells, thus demonstrating a novel manner of modulating the toxicity of a protein toxin. The data also indicate that the inactivation of EF-2 is the rate-limiting step in the intoxication process.

Indexed as

Amino Acid SequenceAnimalsCell FractionationChlorocebus aethiopsCysteine EndopeptidasesCysteine Proteinase InhibitorsDipeptidesDiphtheria ToxinIntracellular FluidMolecular Sequence DataMultienzyme ComplexesMutagenesisOligopeptidesPeptide FragmentsPeptidesProteasome Endopeptidase ComplexCysteine EndopeptidasesCysteine Proteinase InhibitorsDipeptidesDiphtheria Toxindiphtheria toxin fragment AFLAG peptideMultienzyme ComplexesOligopeptidesPeptide FragmentsPeptidesProteasome Endopeptidase ComplexRecombinant Fusion Proteins

Identifiers

PMID9430652
PMCPMC1170411
OpenAlexW1999289759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.